PORTLAND A New York man whom authorities said supplied a North Berwick resident with oxycodone and oxymorphone pills over a period of more than two years was found guilty of conspiracy to distribute the drugs following a two-day jury trial in federal court.
Damian Corbett, 40, faces up to 20 years in prison and a $1 million fine, according to a news release issued Thursday by the Office of U.S. Attorney Thomas Delahanty II. He will be sentenced after the completion of a presentence investigation report by the U.S. Probation office.
According to court records, on Dec. 16, 2014, federal agents and task force officers seized approximately 1,000 oxycodone and oxymorphone pills at the home of the unnamed North Berwick resident. According to Delahanty, investigators learned that since at least June 2013, Corbett had been supplying those pills to the resident who, in turn, distributed them in southern Maine. On Dec. 19, 2014, Corbett was arrested shortly after he met with the resident, and agents said they seized about $2,500 that he had just been paid for a delivery.
The case was investigated by the U.S. Drug Enforcement Administration, Portsmouth Tactical Diversion Squad, North Berwick Police Department, Maine State Police, and York County Sheriff s Office.
Comments are not available on this story. Read more about why we allow commenting on some stories and not on others.
We believe it's important to offer commenting on certain stories as a benefit to our readers. At its best, our comments sections can be a productive platform for readers to engage with our journalism, offer thoughts on coverage and issues, and drive conversation in a respectful, solutions-based way. It's a form of open discourse that can be useful to our community, public officials, journalists and others.
We do not enable comments on everything — exceptions include most crime stories, and coverage involving personal tragedy or sensitive issues that invite personal attacks instead of thoughtful discussion.
You can read more here about our commenting policy and terms of use. More information is also found on our FAQs.
Show less